Within the pancreas, GIP and GLP-1 together promote -cell proliferation and inhibit cell death, thereby resulting in pancreatic -cell mass-increase, while GIP enhances postprandial glucagon response and GLP-1 suppresses it [9, 10]
FDA-approved brand options (Wegovy, Ozempic, Zepbound, Mounjaro) are reviewed by the FDA for safety, effectiveness, and quality and are a separate pathway
Calorie counting is less important on GLP-1 than it was before
The cardiovascular advantages of GLP-1 receptor agonists go beyond blood sugar management
By enhancing these hormonal signals, it promotes fullness, reduces food intake, boosts fat burning, and improves insulin sensitivity
Owing to overgrowing population across the world, reduced farming land, poor bioavailability of M